MedPath

Weight loss in obese women with Polycystic Ovary Syndrome (PCOS)

Not Applicable
Completed
Conditions
Obesity, polycystic ovarian syndrome/weight loss, fertility
Nutritional, Metabolic, Endocrine
Polycystic ovarian syndrome
Registration Number
ISRCTN01915371
Lead Sponsor
Robert Gordon University (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
66
Inclusion Criteria

1. Obese women body mass index (BMI) > 30 kg/m2
2. Aged between 20-40 years old who wish to conceive and have polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria, (2003)

Exclusion Criteria

1. Previously diagnosed diabetics (both types 1 and 2)
2. History of renal disorder, hepatic disease, thyroid disease or cancer
3. Eating disorders
4. Weight altering medication
5. Weight loss > 2% in the last 3 months
6. Major cardiovascular or cerebrovascular event in the last 6 months
7. Pregnancy or lactation
8. Miscarriage in the last 3 months
9. Following contraception methods
10. Cardiac dysrhythmia
11. Porphyria (disorder of certain enzymes in the haeme biosynthetic pathway)
12. Thrombosis
13. Total lactose intolerance
14. Convulsions, seizures, epilepsy
15. Major depressive episodes, psychotic episodes, schizophrenia
16. Serious illness, injury or trauma/surgery in the last 3 months or due to undergo surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Weight loss-will be measured with subjects wearing light clothing and no shoes, on a calibrated digital scale (Tanita Body Composition Analyzer, type BC 410 MA III)<br>2. Ovulation-A calendar will be provided for the patients to keep track of their menses for the 12 month duration of the study
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath